NasdaqGM - Nasdaq Real Time Price USD

Disc Medicine, Inc. (IRON)

31.84 +0.83 (+2.68%)
At close: May 14 at 4:00 PM EDT
Loading Chart for IRON
DELL
  • Previous Close 31.01
  • Open 30.97
  • Bid 31.75 x 400
  • Ask 31.88 x 300
  • Day's Range 30.97 - 32.31
  • 52 Week Range 25.60 - 77.60
  • Volume 316,823
  • Avg. Volume 498,924
  • Market Cap (intraday) 787.139M
  • Beta (5Y Monthly) --
  • PE Ratio (TTM) --
  • EPS (TTM) -3.31
  • Earnings Date Aug 9, 2024 - Aug 13, 2024
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est 57.33

Disc Medicine, Inc., together with its subsidiaries, a clinical-stage biopharmaceutical company, engages in the discovery, development, and commercialization of novel treatments for patients suffering from serious hematologic diseases in the United States. The company has assembled a portfolio of clinical and preclinical product candidates that aim to modify fundamental biological pathways associated with the formation and function of red blood cells, primarily heme biosynthesis and iron homeostasis. Its pipeline includes bitopertin for the treatment of erythropoietic porphyrias, including erythropoietic protoporphyria, X-linked protoporphyria, and diamond-blackfan anemia; DISC-0974 for the treatment of anemia of myelofibrosis, and anemia of chronic kidney disease; and DISC-3405 for the treatment of polycythemia vera, and other hematologic disorders. The company's preclinical programs include DISC-0998, for the treatment of anemia associated with inflammatory diseases. Disc Medicine, Inc. was founded in 2017 and is headquartered in Watertown, Massachusetts.

www.discmedicine.com

78

Full Time Employees

December 31

Fiscal Year Ends

Recent News: IRON

Performance Overview: IRON

Trailing total returns as of 5/14/2024, which may include dividends or other distributions. Benchmark is

.

YTD Return

IRON
44.88%
S&P 500
10.00%

1-Year Return

IRON
4.10%
S&P 500
27.22%

3-Year Return

IRON
87.69%
S&P 500
27.58%

5-Year Return

IRON
--
S&P 500
55.21%

Compare To: IRON

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: IRON

Valuation Measures

Annual
As of 5/14/2024
  • Market Cap

    787.14M

  • Enterprise Value

    446.55M

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    --

  • Price/Book (mrq)

    2.33

  • Enterprise Value/Revenue

    --

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    0.00%

  • Return on Assets (ttm)

    -20.37%

  • Return on Equity (ttm)

    -28.23%

  • Revenue (ttm)

    --

  • Net Income Avi to Common (ttm)

    -80.6M

  • Diluted EPS (ttm)

    -3.31

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    342.62M

  • Total Debt/Equity (mrq)

    0.60%

  • Levered Free Cash Flow (ttm)

    -51.57M

Research Analysis: IRON

Company Insights: IRON

Research Reports: IRON

People Also Watch